Comparative study of functionalized imidazolium and benzimidazolium salts
of functionalized imidazolium and benzimidazolium is relevant.
Herein, we report our findings on the effectiveness of various
imidazolium and benzimidazolium salts functionalized with hy-
droxyl and carboxylate moieties as precursors of NHCs. In addition,
the catalytic systems formed in combination with palladium(II) ace-
tate are compared in the Suzuki reaction.
1494 (C¼N); δH (300 MHz, CD3OD): 3.93 (2H, qd, J = 9.8, 5.3 Hz,
NCH2), 4.24–4.35 (1H, m, CHO), 4.36–4.46, 4.53 (1H, 1H, m, dd, J =
14.4, 3.8, CH2O), 6.86–7.02 (3H, m, ArH), 7.19–7.33 (4H, m, ArH)
7.53–7.61 (1H, m, ArH), 7.62–7.70 (1H, m, ArH), 8.13 (1H, s, NCHN);
δC (75 MHz, CD3OD): 48.8 (NCH2), 69.4 (CHOH), 70.1 (CH2O), 111.6,
115.6, 120.0, 122.2, 123.4, 124.2, 130.6 (ArCH), 135.4, 143.8 (ArC),
145.6 (NCHN), 159.9 (ArC–Ph); m/z (HPLC-ESI): 269 [M]+, MS2 [269]:
159 (20%), 119 (100%).
2-(Benzo[d]imidazol-1-yl)cyclohexanol (6). Off white solid; m.p.
156–158°C (acetone–hexane); Rf 0.74 (MeOH–AcOEt, 2:1); ν 1496
(C¼N); δH (300 MHz, CDCl3): 1.32–1.63, 1.67–1.95 (3H, 3H, 2m, CH2
ring), 2.01 (1H, d, J = 12.8 Hz, CH2 ring), 2.15–2.30 (1H, m, CH2 ring),
3.87–4.06 (2H, m, NCHCHO), 5.70 (1H, s, OH), 7.09 (1H, t, J = 7.6 Hz,
ArH), 7.20 (1H, t, J = 7.6 Hz, ArH), 7.37–7.49 (3H, m, ArH and NCHN);
δC (75 MHz, CDCl3): 24.6, 25.4, 32.0, 34.6 (CH2 ring), 62.6 (CHNCHO),
72.3 (CHO), 110.8, 119.5, 122.2, 122.7 (ArCH), 133.9, 140.8 (ArC),
142.9 (NCHN); m/z (HPLC-ESI): 217 [M]+, MS2 [217]: 119 (100%).
Experimental
All commercially available reagents and solvents were purchased
(Acros, Aldrich, Fluka) and used without further purification.
Ultrasound-irradiated reactions were performed using a Selecta
Ultrasons bath (6 l, 150 W). The optimization reactions were carried
out with a Carrousel 12 Plus™ Reaction Station. Melting points were
determined with a Reichert Thermovar hot plate apparatus and are
1
uncorrected. H NMR and 13C NMR spectra were recorded at the
technical service of the University of Alicante (SSTTI – UA),
employing a Bruker AC-300 or a Bruker Advance-400. CDCl3 was
employed as solvent, unless otherwise stated, and tetrame-
thylsilane as internal reference. Chemical shifts (δ) are given in
ppm and the coupling constants (J) in Hz. Low-resolution mass
spectra (EI) were obtained at 70 eV with an Agilent 5973 Network
spectrometer, with fragment ions m/z reported with relative inten-
sities (%) in parentheses. Low-resolution HPLC with electrospray
ionization (HPLC-ESI) mass spectra were recorded at the technical
service of the University of Alicante (SSTTI – UA), employing an
Agilent 1100 series apparatus with the possibility of MS/MS.
Infrared spectra were recorded with an FT-IR 4100 LE (JASCO, Pike
Miracle ATR) spectrometer. Spectra were recorded from neat sam-
Hydroxyl-Functionalized Imidazolium and Benzimidazolium
Chlorides
In a round-bottom flask, the hydroxyl-functionalized imidazolium
(1 or 2) or benzimidazolium (5 or 6) (5 mmol), acetonitrile (10 ml)
and benzyl chloride (1.1 eq., 5.5 mmol) were added. The mixture
was refluxed with stirring for 16 h. Finally the solvent was removed
under reduced pressure and the product was purified by recrystal-
lization from acetone.
1-Benzyl-3-(2-hydroxy-2-phenylethyl)imidazolium chloride (3).
White solid; m.p. 190–192°C (acetone); Rf 0.48 (AcOEt–MeOH, 1:1);
ν 1561 (C¼N); δH (400 MHz, CD2Cl2): 4.34 (1H, dd, J = 13.7, 7.1 Hz,
NCHHCH), 4.72 (1H, dd, J = 13.7, 3.1 Hz, NCHHCH), 5.05–5.16 (1H,
m, CHOH), 5.27 (2H, s, NCH2Ph), 6.58 (1H, d, J = 5.7 Hz, OH), 6.93
(1H, t, J = 1.8 Hz, CHCH), 7.00 (1H, t, J = 1.7 Hz, CHCH), 7.16–7.38
(10H, m, ArH), 9.94 (s, 1H, NCHN); δC (100 MHz, CDCl3): 53.3, 56.9
(NCH2Ph; NCH2CHOH), 70.9 (CHOH), 120.6, 123.5, 126.0, 127.8,
128.5, 128.7, 129.4 (ArC), 132.7, 137.4 (NCHCHN, NCHCHN), 140.0
(NCHN).
ples, without further preparation, and results are given in cmꢀ1
.
Analytical TLC was performed on Merck aluminium sheets with sil-
ica gel 60 F254, 0.2 mm thick. Silica gel 60 (0.04–0.06 mm) was
employed for flash chromatography. The conversion of the reac-
tions and purity of the products were determined by GC analysis
using a Younglin 6100GC, equipped with a flame ionization detec-
tor and a Phenomenex ZB-5MS column (5% PH-ME siloxane): 30 m
(length), 0.25 mm (inner diameter) and 0.25 μm (film).
1-Benzyl-3-(2-hydroxycyclohexyl)imidazolium chloride (4). White
solid; m.p. 153–155°C (acetone); Rf 0.56 (AcOEt–MeOH, 2:1); ν 1557
(C¼N); δH (300 MHz, CDCl3): 1.20–1.60, 1.65–1.95, 2.00–2.20 (3H,
3H, 2H, 3m, 4 × CH2 ring), 2.75–3.10 (1H, br s, OH), 3.60–3.80,
4.22–4.37 (1H, 1H, 2m, NCHCO, CHOH), 5.45 (1H, d, J = 14.5 Hz,
PhCHH), 5.52 (1H, d, J = 14.5 Hz, PhCHH), 7.22–7.29, 7.31–7.39,
7.39–7.51 (1H, 3H, 3H, 3m, ArH and NCHCHN), 10.06 (1H, s, NCHN);
δC (75 MHz, CDCl3): 24.2, 24.7, 31.5, 34.5 (CH2 ring), 53.3 (CH2Ph),
66.1 (NCHCHOH), 72.1 (HOCH), 120.9, 121.4 (NCHCHN), 129.1,
129.3(5), 129.4(1) (ArCH), 133.3 (ArC), 136.6 (NCHN); m/z (HPLC-ESI):
257 [M ꢀ Cl]+, MS2 [257]: 159 (100%), 91 (60).
Hydroxyl-Functionalized Imidazoles and Benzimidazoles
Imidazole or benzimidazole (10 mmol) and the corresponding
epoxide (10 mmol) were placed into a high-pressure flask. The neat
mixture was stirred at 60°C for 16 h and the product was purified
from the crude reaction by recrystallization from acetone–hexane.
2-(Imidazol-1-yl)-1-phenylethanol (1). Off white solid; m.p.
130–134°C (acetone–hexane); Rf 0.72 (MeOH–AcOEt, 2:1); ν 3139,
3118 (CH2); δH (300 MHz, CDCl3): 4.07–4.13 (2H, m, CH2), 4.91 (1H,
dd, J = 7.0, 4.6 Hz, CHOH), 6.88, 6.92 (2H, 2s, NCHCHN), 7.28–7.40
(6H, m, NCHN, ArH); δC (75 MHz, CDCl3): 55.3 (NCH2), 74.2 (CHO),
121.5, 127.1, 128.4, 129.4, 129.7, 139.0 (ArC, ArCH, NCHCHN), 143.0
(NCHN); m/z (HPLC-ESI): 189 [M]+, MS2 [189]: 69 (100%).
2-(Imidazol-1-yl)cyclohexanol (2). White solid; m.p. 120–124°C
(acetone–hexane); Rf 0.67 (MeOH–AcOEt, 2:1); ν 1500 (C¼N); δH
(300 MHz, CDCl3): 1.26–1.51, 1.58–1.76, 1.76–1.90, 1.98–2.10, 2.11–
2.22 (3H, 1H, 2H, 1H, 1H, 2H, 5m, CH2 ring), 3.53–3.76 (2H, m,
NCHCHO), 6.86, 6.91 (1H, 1H, 2s, NCHCHN), 7.35 (1H, s, NCHN); δC
(75 MHz, CDCl3): 24.5, 25.2, 32.4, 34.3 (CH2 ring), 64.0 (CHN), 73.0
(CHO), 117.3, 128.6 (NCHCHN), 136.3 (NCHN); m/z (HPLC-ESI): 167
[M]+, MS2 [167]: 69 (100%).
1-Benzyl-3-(2-hydroxy-3-phenoxypropyl)benzimidazolium chlo-
ride (7). Off white solid; m.p. 97–100°C (acetone); ν 1551 (C¼N); δH
(300 MHz, CDCl3): 3.86 (1H, t, J = 9.1 Hz, NCHHCHOH), 4.19 (1H,
dd, J = 9.6, 4.5 Hz, NCHHCHOH), 4.59 (1H, m, CHOH), 4.87–5.01
(2H, m, OCH2), 5.78 (2H, s, NCH2Ph), 6.48 (1H, d, J = 6.7 Hz, OH),
6.87 (2H, dd, J = 8.7, 0.9 Hz, ArH), 6.96 (1H, t, J = 7.4 Hz, ArH),
7.20–7.55 (10H, m, ArH), 7.63–7.80 (1H, m, ArH), 10.94 (1H, s, NCHN);
δC (75 MHz, CDCl3): 50.1, 51.7 (NCH2), 67.0 (CHOH), 68.3 (OCH2),
113.2, 113.7, 114.6, 121.3, 126.9, 127.0, 128.2, 129.2, 129.4, 129.6
(ArCH), 131.0, 132.2, 132.7 (ArC), 143.9 (NCHN), 158.0 (ArC-O); m/z
(HPLC-ESI): 359 [M ꢀ Cl]+, MS2 [359]: 265 (18%), 249 (24), 222
(100), 221 (25), 209 (53), 207 (21), 145 (18), 133 (12), 132 (15), 131
(78), 119 (40).
1-(Benzo[d]imidazol-1-yl)-3-phenoxypropan-2-ol (5). Brown solid;
m.p. 139–141°C (acetone–hexane); Rf 0.79 (MeOH–AcOEt, 2:1); ν
Appl. Organometal. Chem. 2015, 29, 624–632
Copyright © 2015 John Wiley & Sons, Ltd.
wileyonlinelibrary.com/journal/aoc